Literature DB >> 22085312

Secondary nucleating sequences affect kinetics and thermodynamics of tau aggregation.

Christopher L Moore1, Michael H Huang, Shauna A Robbennolt, Kellen R Voss, Benjamin Combs, T Chris Gamblin, Warren J Goux.   

Abstract

Tau protein was scanned for highly amyloidogenic sequences in amphiphilic motifs (X)(n)Z, Z(X)(n)Z (n ≥ 2), or (XZ)(n) (n ≥ 2), where X is a hydrophobic residue and Z is a charged or polar residue. N-Acetyl peptides homologous to these sequences were used to study aggregation. Transmission electron microscopy (TEM) showed seven peptides, in addition to well-known primary nucleating sequences Ac(275)VQIINK (AcPHF6*) and Ac(306)VQIVYK (AcPHF6), formed fibers, tubes, ribbons, or rolled sheets. Of the peptides shown by TEM to form amyloid, Ac(10)VME, AcPHF6*, Ac(375)KLTFR, and Ac(393)VYK were found to enhance the fraction of β-structure of AcPHF6 formed at equilibrium, and Ac(375)KLTFR was found to inhibit AcPHF6 and AcPHF6* aggregation kinetics in a dose-dependent manner, consistent with its participation in a hybrid steric zipper model. Single site mutants were generated which transformed predicted amyloidogenic sequences in tau into non-amyloidogenic ones. A M11K mutant had fewer filaments and showed a decrease in aggregation kinetics and an increased lag time compared to wild-type tau, while a F378K mutant showed significantly more filaments. Our results infer that sequences throughout tau, in addition to PHF6 and PHF6*, can seed amyloid formation or affect aggregation kinetics or thermodynamics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085312      PMCID: PMC3237831          DOI: 10.1021/bi2014745

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  75 in total

Review 1.  Characterization of paired helical filaments by scanning transmission electron microscopy.

Authors:  Hanna Ksiezak-Reding; Joseph S Wall
Journal:  Microsc Res Tech       Date:  2005-07       Impact factor: 2.769

2.  Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.

Authors:  Nicholas M Kanaan; Gerardo A Morfini; Nichole E LaPointe; Gustavo F Pigino; Kristina R Patterson; Yuyu Song; Athena Andreadis; Yifan Fu; Scott T Brady; Lester I Binder
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

3.  Self-assembly of a beta-sheet protein governed by relief of electrostatic repulsion relative to van der Waals attraction.

Authors:  M R Caplan; P N Moore; S Zhang; R D Kamm; D A Lauffenburger
Journal:  Biomacromolecules       Date:  2000       Impact factor: 6.988

4.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure.

Authors:  O Schweers; E Schönbrunn-Hanebeck; A Marx; E Mandelkow
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

5.  The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments.

Authors:  Warren J Goux
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

6.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

7.  Tau polymerization: role of the amino terminus.

Authors:  T Chris Gamblin; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

8.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

9.  A soluble oligomer of tau associated with fiber formation analyzed by NMR.

Authors:  Dylan W Peterson; Hongjun Zhou; Frederick W Dahlquist; John Lew
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

10.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  8 in total

1.  Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.

Authors:  Pritam Ganguly; Thanh D Do; Luca Larini; Nichole E LaPointe; Alexander J Sercel; Madeleine F Shade; Stuart C Feinstein; Michael T Bowers; Joan-Emma Shea
Journal:  J Phys Chem B       Date:  2015-03-24       Impact factor: 2.991

Review 2.  Structural evaluations of tau protein conformation: methodologies and approaches.

Authors:  Nicole L Zabik; Matthew M Imhof; Sanela Martic-Milne
Journal:  Biochem Cell Biol       Date:  2017-03-09       Impact factor: 3.626

3.  How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?

Authors:  Liang Xu; Jie Zheng; Martin Margittai; Ruth Nussinov; Buyong Ma
Journal:  ACS Chem Neurosci       Date:  2016-02-24       Impact factor: 4.418

4.  Novel cell-penetrating-amyloid peptide conjugates preferentially kill cancer cells.

Authors:  John R Veloria; Luxi Chen; Lin Li; Gail A M Breen; Jiyong Lee; Warren J Goux
Journal:  Medchemcomm       Date:  2017-12-05       Impact factor: 3.597

5.  Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.

Authors:  Sang-Won Min; Xu Chen; Tara E Tracy; Yaqiao Li; Yungui Zhou; Chao Wang; Kotaro Shirakawa; S Sakura Minami; Erwin Defensor; Sue Ann Mok; Peter Dongmin Sohn; Birgit Schilling; Xin Cong; Lisa Ellerby; Bradford W Gibson; Jeffrey Johnson; Nevan Krogan; Mehrdad Shamloo; Jason Gestwicki; Eliezer Masliah; Eric Verdin; Li Gan
Journal:  Nat Med       Date:  2015-09-21       Impact factor: 53.440

6.  Interactions between amyloid-β and Tau fragments promote aberrant aggregates: implications for amyloid toxicity.

Authors:  Thanh D Do; Nicholas J Economou; Ali Chamas; Steven K Buratto; Joan-Emma Shea; Michael T Bowers
Journal:  J Phys Chem B       Date:  2014-09-15       Impact factor: 2.991

7.  Structure-based inhibitors of tau aggregation.

Authors:  P M Seidler; D R Boyer; J A Rodriguez; M R Sawaya; D Cascio; K Murray; T Gonen; D S Eisenberg
Journal:  Nat Chem       Date:  2017-11-20       Impact factor: 24.427

8.  Mapping interactions with the chaperone network reveals factors that protect against tau aggregation.

Authors:  Sue-Ann Mok; Carlo Condello; Rebecca Freilich; Anne Gillies; Taylor Arhar; Javier Oroz; Harindranath Kadavath; Olivier Julien; Victoria A Assimon; Jennifer N Rauch; Bryan M Dunyak; Jungsoon Lee; Francis T F Tsai; Mark R Wilson; Markus Zweckstetter; Chad A Dickey; Jason E Gestwicki
Journal:  Nat Struct Mol Biol       Date:  2018-04-30       Impact factor: 15.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.